
    
      This study supports the collection of tumor specimens for CLIA-certified genomic testing and
      research testing in parallel. CLIA-certified tests have established measurements of accuracy
      and precision which allow for return of results. This study does not involve treatment, only
      testing, which could be used to meet eligibility criteria in other trials.
    
  